Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.08 +0.34 (+7.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) posted quarterly Prepaid Assets of $1.4 million for Q1 2026, down 19.33% year-over-year from $1.8 million in Q1 2025, and up 45.67% quarter-over-quarter from $994000.0 in Q4 2025.

Analysis

Orchestra BioMed Holdings (OBIO) Prepaid Assets (2020 - 2026) Analysis & Trends

Orchestra BioMed Holdings (OBIO) has reported Prepaid Assets for 7 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets fell 19.33% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 19.33% YoY), while the FY2025 annual figure was $994000.0, down 52.53% from the prior year.
  • Prepaid Assets grew to $1.4 million in Q1 2026 per OBIO's latest filing, from $994000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $2.3 million in Q1 2023 and bottomed at $36417.0 in Q2 2022.
  • Historically, Prepaid Assets has averaged $1.2 million across 5 years, with a median of $1.3 million in 2023.
  • Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 65.54% — and 2023, when it soared 3931.08%.
  • Orchestra BioMed Holdings' Prepaid Assets stood at $533000.0 in 2022, then jumped by 139.02% to $1.3 million in 2023, then jumped by 64.36% to $2.1 million in 2024, then plunged by 52.53% to $994000.0 in 2025, then surged by 45.67% to $1.4 million in 2026.
  • Business Quant data shows OBIO's Prepaid Assets at $1.4 million in Q1 2026, $994000.0 in Q4 2025, and $1.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Orchestra BioMed Holdings 322.25 Mn 127.72 Mn 63,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 977,000.00
Mar 31, 2026 1.45 Mn
Dec 31, 2025 994,000.00
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.69 Mn
Mar 31, 2025 1.80 Mn
Dec 31, 2024 2.09 Mn
Sep 30, 2024 1.28 Mn
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.21 Mn
Dec 31, 2023 1.27 Mn
Sep 30, 2023 1.12 Mn
Jun 30, 2023 1.47 Mn
Mar 31, 2023 2.34 Mn
Dec 31, 2022 533,000.00
Sep 30, 2022 137,338.00
Jun 30, 2022 36,417.00
Mar 31, 2022 71,292.00
Dec 31, 2021 46,667.00
Sep 30, 2021 81,167.00